Top 10 Leading Companies In Sepsis Diagnostics Industry
The global sepsis diagnostics market size is expected to reach USD 1.18 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.5% from 2021 to 2027. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected to propel market growth over the forecast period.
Increasing regulatory approval and the
introduction of technologically advanced diagnostic solutions for sepsis are
expected to facilitate market growth over the forecast period. In May 2018, T2
Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received
the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of
specific sepsis-causing bacterial pathogens in human whole blood specimens.
The outbreak of COVID-19 is another
important factor boosting the demand for sepsis diagnostics around the globe.
Symptoms of sepsis such as multiorgan injuries develop in around 2.0% to 5.0%
of COVID-19 cases 8 to 10 days post-hospitalization, based on the estimates of
the Global Sepsis Alliance. To manage this situation, the Biomedical Advanced
Research and Development Authority, in May 2020, extended its partnership with
Beckman Coulter for the development of a digital algorithm to detect sepsis in patients with
COVID-19.
Request
Free Sample Report: https://www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market
Sepsis Diagnostics Market Report Highlights
·
By product, blood culture media held the largest
share in 2020 as it is the most accurate mode of testing for the diagnosis of
this disease. The software segment is anticipated to witness the fastest growth
over the forecast period owing to new product developments in this field
·
On the basis of technology, the molecular diagnostics segment
is anticipated to exhibit a lucrative CAGR over the forecast period owing to
its high sensitivity, accuracy, and less turnaround time
·
Based on the pathogen, in 2020, the bacterial sepsis
segment held the largest revenue share owing to its high prevalence
·
North America dominated the market in 2020 due to
high awareness, a favorable reimbursement scenario, and the presence of
established players
·
The Asia Pacific is projected to witness lucrative
growth over the forecast period owing to the presence of a large target
population in emerging economies, such as India and China
Key Companies & Market Share Insights
The
key players operating in the market are adopting inorganic growth strategies,
such as mergers and partnerships, for the development of novel diagnostic
solutions. For instance, in January 2020, Roche and Inotrem SA, a France-based
company, went into a strategic agreement for the commercialization of a
companion diagnostics test intended for septic shock. Moreover, in May 2020,
the Biomedical Advanced Research and Development Authority (BARDA) collaborated
with Beckman Coulter for the development of a digital algorithm to identify
sepsis in patients with COVID-19. Some prominent players in the global sepsis
diagnostics market include:
Browse Full Report (Tables & Figures) @https://www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market

Comments
Post a Comment